SchanbacherC.F., VannessE.R., DaoudM.S., TefferiA., SuW.P.Pseudoporphyria: a clinical and biochemical study of 20 patients.Mayo Clin Proc2001; 76(5): 488–92.
2.
GreenJ.J., MandersS.M.Pseudoporphyria.J Am Acad Dermatol2001; 44(1): 100–8.
3.
ChazotC., ChazotI., CharraB., TerratJ.C., VanelT., CalemardE.Functional study of hands among patients dialysed for more than 10 years.Nephrol Dial Transplant1993; 8(4): 347–51.
4.
FelixR.H., SilvaM.F.Jr., AlmeidaJ.B., NetoP.B.Pseudoporphyria associated with hemodialysis.Kidney Int2011; 79(1): 140.
5.
GlynneP., DeaconA., GoldsmithD., PuseyC., ClutterbuckE.Bullous dermatoses in end-stage renal failure: porphyria or pseudoporphyria?Am J Kidney Dis1999; 34(1): 155–60.
6.
LomaestroB.M., MaloneM.Glutathione in health and disease: pharmacotherapeutic issues.Ann Pharmacother1995; 29(12): 1263–73.
7.
HoldinessM.R.Clinical pharmacokinetics of N-acetylcysteine.Clin Pharmacokinet1991; 20(2): 123–34.
8.
GuiotokuM.M., Pereira FdeP., MiotH.A., MarquesM.E.Pseudoporphyria induced by dialysis treated with oral N-acetylcysteine.An Bras Dermatol2011; 86(2): 383–5.
9.
El KabbajD., LaalouA., AlouaneZ., BahadiA., OualimZ.Hemodialysisassociated pseudoporphyria resistant to N-acetylcysteine.Saudi J Kidney Dis Transpl2011; 22(2): 311–4.
